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  Abstract - Scope of Translational Medicine is to speed 
the development of new compounds of medical protocols 
and/or treatments to improve patient’s quality of life. 
Translational medicine represents the synergy between 
epidemiology, basic research and clinical trials, and is 
based upon Innovation Management and Research 
Development in medicine. Being the speed and 
progression up to the patient a key issue of Translational 
Medicine, the innovation process ought to be pursued 
according to rigorous protocols embedded on a research 
development path capable of decreasing the lead time at 
the most. Translational Medicine represents a goal to be 
pursued by all involved actors, from academic researchers 
to clinicians, patients and others than can be seen as a 
network of co-creating actors engaged for the ultimate 
patient benefit. To underpin Translational Medicine 
advantages and determinants, the paper approaches the 
issue by adopting a systems thinking perspective, capable 
of highlighting the key issues to be considered. 
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service co-creation; innovation management; systems 
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I.  SCIENTIFIC AND CLINICAL GOALS OF 
TRANSLATIONAL MEDICINE 
 
There is growing evidence of the importance of 
translational medicine in the improvement of patient 
outcome [1, 2]. Reducing human disease and mortality is, 
in fact, the end purpose which translational medicine is 
generally and commonly recognized to be oriented to [3, 
4]. 
However, the patient outcome perspective ought not 
to be the only interpretation key of translational medicine, 
since it produces different values for different actors 
looking at various aspects of this medical approach [5]. 
For academics, it represents the chance to confirm and 
validate novel concepts or to find new ones out with the 
hope they could turn into effective clinical applications 
and be relevant to human disease [6]; for patients as well 
as for clinicians, it refers to the need of accelerating the 
capture of the biomedical research benefit, wishing the 
gap between “what we know and what we practice” to be 
bridged [7, 5]; for those who invested in, translational 
medicine provides financial returns [8]. 
Despite the variegated list of benefits and 
stakeholders, it seems possible to identify a unifying 
purpose, capable of complying with the expectations and 
needs of all involved actors [5] once we higher the level of 
observation and analyze its beneficial effects on society. 
The ultimate goal of translational medicine, in fact, may 
be identified in the development of new treatments and 
insights for the improvement of health across populations 
[9, 10, 11]. This implies that translational medicine (also 
called translational research) not only aims to produce 
values and bring them to the patient. Its essence lies in 
validating the potentiality of novel discoveries whereas 
enhancing the success, feasibility and efficiency of 
discovery validation. In other words its ultimate goal lays 
in identifying in the process of clinical testing to human 
disease (through direct observation) what the obstacles are 
[12, 13] and allowing basic scientists as well as physicians 
to share their expertise to indentify and compare the 
challenges at the interface between basic and clinical 
investigation, proposing integrated and integrating 
solutions to increase the efficiency of the process [8]. 
This means that the scientific phase of the research 
and the applied one both equally contribute to reach the 
common purpose of translational medicine -which is 
claimed to be finding alleviation to human suffering [6]. 
As confirmed by Littman [5], “translational research 
should be seen as enabled by ongoing efforts in basic and 
clinical research and not competing with them”. 
Translational medicine draws results about disease by 
clinically testing the viability of novel hypothesis [5, 6]. 
Such hypothesis may reveal to be wrong or irrelevant to 
the care purposes. Currently, the problem is that if “in 
times of abundance, efficiency may not be the highest 
priority, and scientists might have the chance to indulge 
the luxury of speculative adventures in the world of the 
unknown [...] in these times of restricted funding 
opportunity, it behooves us to select our scientific 
challenges parsimoniously by constantly confronting our 
intuitions with the reality of human pathology” [6]. In 
other words, application criteria must ensure positive 
results in a framework of appropriateness, financial 
sustainability, interventions equity and integration. 
Hence translational medicine success encompasses 
not only scientific and operational, but also financial, 
ethical, social, regulatory and legislative contingencies 
[5]. 
 
II. INNOVATION MANAGEMENT AND 
TECHNOLOGY TRANSFER IN HEALTH 
 
Medicine, and health treatment advance lays upon 
innovation. Research and development programs involve 
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most of health organizations in most of countries, and are 
expensive and long lasting, due to results uncertainty of 
many research pathways aimed to mitigate the negative 
effects of important diseases affecting human population. 
Innovation in health contexts results from both 
scientific and technological progress and often is strictly 
depending on their reciprocal inferences. In fact, health 
innovation is the result of both biomedical research 
(genomics, neuroscience, molecular oncology, etc..) and 
technology (medical diagnostics, biotechnology, health 
informatics, electronic devices, etc..). Consider, e.g., the 




• diagnostic imaging [14]. 
Technological developments in these mentioned fields 
are able to characterize and deeply transform the results of 
medicine as well as the processes of care. At the same 
time innovation and technology transfer determine strong 
implications on health services and consequently 
managerial, organizational [15] and operational needs of 
modern health systems, with a relevant impact on both 
health and costs. Managing health care organizations is 
mainly about managing innovation [16, 17]. Therefore, 
innovation and managerial dimension of health services 
are highly interconnected factors. In this mainframe we 
may observe how the issue of sustainability of an health 
system calls for efficient government models and 
practices. In other words, the sustainability of the health 
systems largely depends on the ability to govern the entry 
as well as the implementation and results of innovative 
technologies both in clinical practice and in science. 
Hence, although exploiting existing competencies 
may provide short-term success, competence exploration 
may become the hindrance for organization’s long-term 
viability and competitive advantage [18]. Innovation, in 
fact, can bring substantial benefits to both economic 
variables (although in the long-run) and qualitative ones, 
such as in the training of professionals, e.g. projects of 
lifelong learning, aimed at ensuring a high level of end 
quality performance. 
Thus, effectiveness and efficiency of the new 
technologies are guaranteed by technology transfer. 
However technology is something complex to transfer, 
even more in healthcare as a turbolent, challenging 
environment. In this context, in fact, solutions should be 
scalable, replicable and versatile to different operative 
scenarios and users. Moreover health advances are 
constrained by financial issues (as rising costs and lack of 
funds), limited access to information, coordination 
problems. With reference to this last aspect, it is possible 
to state that processes, components and even people of a 
health system are not always coordinated, and errors in 
duplications, missing information or wrong one occur. 
Since many players are involved in healthcare innovation 
processes, each one with different priorities and finalities, 
it is necessary to overcome such divergences that before 
being operational, refer to language, education, culture, 
purposes. Currently, it is technology transfer and 
integration to make the healthcare systems smarter [19] – 
that is – with better, faster and more detailed information 
within the actors involved in, reducing errors and 
inefficiencies in the transfer, allowing the system to 
capture, manage and turn data into relevant information in 
real time. Thanks to ICT (Information and 
Communication Technology) platforms, including people, 
processes and knowledge, alignment of scope is created as 
well as reduction of coordination and transaction costs 
between involved actors [20]. Consider, in this regard, the 
strong advances accomplished by eHealth (or health in 
net) techniques. eHealth is the practice of healthcare 
through the support of informatics tools, highly skilled 
professionals and practitioners-patients communication 
techniques. That represents a major challenge in the field 
of technology transfer. eHealth services are in fact aimed 
at: 
• improving the efficiency of primary health care 
through the integration in the network of health 
professionals; 
• supporting the integration of various health 
organizations at a local level in order to facilitate the 
processes of care; 
• facilitating access to services by users, enhancing and 
facilitating the choice of the citizens through the 
interoperability between the systems; 
• supporting the control of health expenditure, by 
monitoring the demand for health services. 
Hence, eHealth , and in general ICT, can be 
considered as a tool for health professionals to improve 
not only the quality of care but also the production 
efficiency of the health sector [21], with positive effects in 
terms of sustainability of health systems in their entirety. 
Thus, again, all stakeholders gain from technology 
advances, implementation and transfer. Definitively, e-
based technologies favor the generation of high quantity 
data representing data gathering, registration, elaboration 
and dissemination models [22, 23]. Results seem to be 
encouraging but the challenge even concerns the ability to 
exploit such potentialities. At organizational level, it 
implies the creation of a collaboration and relational 
culture. Innovation networks can be referred to as inter-
organizational networks that ought to be managed 
appropriately in order to bring results [24]. 
 
III. HEALTH SERVICE EMBEDDED IN NETWORKS 
OF CO-CREATING ACTORS 
 
Health is a machine producing and consuming 
performance (services) to create care [25]. However we 
may decline care in various specific results, and health 
systems, shaped either on the model of privatized social 
security (of U.S. origin) or universal model (European 
origin), offer services including: 
• disease prevention [26]; 
• food safety; 
• primary care and continuity of care; 
• emergency and urgency; 
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• hospital care; 
• rehabilitation; 
• pharmaceutical care [27, 28]; 
• care for the elderly; 
• other (blood transfusion services, mental health care, 
palliative care, vegetative states, drug addiction and 
alcoholism). 
Delivery of such services necessarily requires the 
active participation of various stakeholders, including 
institutional actors (local health authorities, hospitals, 
districts, nursing homes, municipalities, volunteer 
associations) which are responsible for the care and the 
provision of services; other national and local agencies of 
planning and control (Region, State, local entities) which 
collaborate in the support and delivery of services; actors 
who are currently in charge of the medical and scientific 
training (Public Administrations, professional 
associations, scientific societies, trade unions of category 
and Universities), citizens, providers of goods and 
services of health organizations; others. 
Each mentioned actor participates in health creation 
and dissemination by exchanging resources and 
information. Hospitals exchange with government 
agencies information to monitor and audit reporting 
activities, with its suppliers for the purchase of goods and 
services. Ministries and Government Agencies collaborate 
for the provision of benefits, facilities and incentives, or 
even hospitals and professionals exchange personal data 
files. 
Researchers and diagnostics exchange programs, 
research and experimental studies; they share expertise, 
skills and know-how at the time of interface between the 
scientific and applied research. Accordingly, within these 
health service networks of actors, we may think of 
translational research as the bridge between academic 
science and clinical practice. Such a bidirectional path 
“from bench to bedside” and back [29, 6], advocates for 
robust, bidirectional information flow [30] and more 
effective collaboration involving academia, industries and 
patients as well [31, 5, 32]. 
As previously mentioned, healthcare systems 
ultimately produce a service
1
: health. The work all actors 
do, aimed to affirm a collective orientation as the 
recognition of health as a public value, necessarily 
requires the involvement and awareness of such 
heterogeneity of actors as health system stakeholders. 
Involved and engaged actors contribute, by sharing their 
resources
2
, to the creation of public health through the 
sharing of goals and pathways, transforming the paradigm 
of clinicians and doctors from passive recipients of 
patients’ needs to pro-active actors engaging with patients 
                                                          
1 Despite the path towards a unifying terminology does not seem finished 
yet a service can be defined more generally as an activity carried out by 
an individual or a group, that benefits others [33]. It is therefore a type of 
activity that provides assistance and experience for the benefit of all 
parties involved in a particular exchange, before, during and after it. 
2 Each actor possesses, and may offer, a crucial contribute by sharing 
various possessed resource, such as (but not limited to): knowledge, 
financial support, innovative solutions, effort, psychological 
involvement, information, professionalism, facilities, etc. 
for their benefit [34]. It is an emerging cultural approach 
aimed at the active promotion of health
3
. In innovative 
health context, it seems essential to build a common sense 
of medicine, which allows all individuals to take control 
of issues with relevant implications and consequences in 
their daily lives and, therefore, require extensive testing 
and acceptance. In other words, there is the necessity of 
introducing a “democratization” process in medicine, 
where partnership is the only alternative to perish for 
every stakeholder [36]. 
More generally, all the actors of a health system are 
involved in the care process, promoting instances of 
improvement [37]. The effectiveness of this process is 
closely related to the interaction and cooperation between 
these parties, which seem to be related to strong 
coordination mechanisms at various levels such as 
operational, political, social, economic, ethical, legal. 
Accordingly, we may posit that, in a more stringent 
service logic, the final value of health is co-created 
through shared activities [38, 39, 40] embedding all actors 
of the healthcare networks, who are thus defined as 
endogenous [41, 42] to the health creation process. At the 
same time, engaged actors can be identified as dynamic, 
active resources, source of competitive advantage for 
health organization as well as of value and innovation [43, 
44] for the whole health system. Hence, actors of a health 
system are regarded as integrators of resources, or as 
entities which exchange resources benefiting from such 
exchange. As such interdependence is revealed, their 
collaboration for the creation of a shared value just as 
public health becomes inevitable. In other words, the logic 
of service leads to a concept of health as a service 
network, as heterogeneous configuration of actors, value 
propositions and exchange of information, resources and 
knowledge [45] that takes place within a dynamic 
network, through relationships and interactions, in order to 
create and sustain collective health as the end shared 
benefit. 
Ultimately, the modern process of health services, of 
assistance approaches and shared nature, could be 
regarded as a cooperative game, aimed at the promotion, 
implementation and coordination of multi-actor 
contribution. Therefore, the way forward is that of a 
system in which the nations, regions, universities, 
businesses and individuals work together to improve the 
conditions necessary for viability, sustainability, 
effectiveness and efficiency of health value in health 
systems [46, 47]. 
 
IV. A SYSTEM VIEW OF HEALTH SERVICE 
 
A Service System (SS), as mentioned, results to be 
strongly interconnected and characterized by multi-actor 
interactions [46] and, thus, may be interpreted as an open 
                                                          
3
 In this sense, an important contribute is attributed to empowerment 
[35], the process of involving all the actors as active players in their path 
to health and wellness, participating and thereby influencing decision-
making processes of care, treatment and rehabilitation. 
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system [48], capable of improving its equilibrium through 
the acquisition, share and supply of resources. Hence a 
National Health Service observed through systems lenses 
in a more ample set of relationships, may be defined a 
System embedded in a more general one due to opening of 
its boundaries and the engagements with an increased 
number of actors/entities [46]. Among these we may 
identify: citizens, health private actors, doctors and so on; 
each actor, in this system, stabilize relations fulfilling 
needs and expectations [49]. Through these networks each 
SS actor may not only access to needed resources, but 
may as well release resources creating a prolific service 
exchange and, consequentially, stimulating a value 
creating system for the overall benefit of the health 
system. 
In other words the suggested systems view highlights 
the role of relationships as promotes of competitiveness, 
viability and survival within service systems in general 
[50] and, of course, within health service systems. In light 
of a relational approach, in fact, each organization may be 
conceived as an active resource involved in reticular 
connections in a many-to-many logic [51, 52]. Hence, 
according to this view, organizations are not isolated, but 
rather they are dependent upon existing relations. This 
network nature requires continuous improvement of 
interactions characterizing all networks knots, in order to 
effectively distribute the shared resources, collaborative 
advantages and cooperative strategies designing 
relationships based upon information, engagement, 
collaboration and trust. 
Each system represents the result of common efforts 
displaced by its active elements; resources assignment and 
distribution, as well as the cooperation advantages and the 
relevance of alliances and cooperative strategies transform 
static networks, through the activation of relationships 
among actors, into a dynamic system, strengthening 
competitiveness and systems advantages [53]. 
Positive interactions among each actor, hence, is 
supportive for the creation of effective health systems in 
which actors engage one with the other in synergy. In this 
optic the system appears to be more competitive as the 
qualification of relationships among actors grows. In other 
words better, stronger and smarter relationships create the 
best survival conditions for health systems. 
 
V.  THE DETERMINANTS OF TRANSLATIONAL 
MEDICINE SUCCESS 
 
Translational medicine context are, as mentioned, 
demanding contexts in which organizations ought to 
pursue continuous improvement and change and this, in 
systems terms, implies that health systems are open and 
strongly dynamic. Effectively this traits stimulate the 
search for homeostatic dynamics as a response to external 
change. As the world is becoming smarter, systems ought 
to become people-centric, information-driven, e-oriented, 
and reciprocal and collective satisfaction should 
encourage actors to cooperation and innovation. Health 
Service systems may hence be seen, adopting a systems 
perspective, as contexts in which co-creation takes place, 
where systems shape themselves into networks proposing 
shared and diffuse value for all involved actors. In order 
words to fulfill such a demanding goal a service logic 
should pervade each organization, favoring diffuse and 
reciprocal resource sharing, thus characterizing 
interactions among actors. According to this view, service 
may hence be interpreted not as a generous and cultural 
attitude. Indeed, service may be identified as a cultural 
attitude, as  a logic, as the enabler and fundamental base 
of health systems, capable of valorizing experiences and 
translational medicine initiatives for all involved actors 
benefits [54, 55]. 
It has been highlighted how innovation and 
technology transfer affect health services, linking the 
quality of care to continuous improvement and to 
translational medicine prolific research contexts. It was 
noted that performance of these technological advances 
depends not only upon researchers’ ability to promote and 
develop wise research pathways, since the contribute of 
numerous other actors appears to be crucial. 
Furthermore we have noted how these numerous 
actors involved in translational medicine success, appear 
to be interconnected in value co-creation networks, in 
which value and service for the patient (and the other 
actors) is the outcome of joint activities within the same 
system. In this perspective, patients, clinicians, private and 
public hospitals, pharmaceutical industries, institutions are 
source and contributors to the system’s performance. This 
latter, indeed, depends on the ability to establish wise and 
profitable relationships among each mentioned actor who, 
being satisfied by the system’s outcomes, easily releases 
the possessed resource to the system, strengthening its 
sustainability. 
As a final consideration we observe that systems 
theories offer interesting insights and contributes to the 
understanding of value co-creation exchanges in health 
networks. According to systems theories, in fact, a service 
logic may be the enabler of harmonic interactions and 
satisfactory exchanges among involved actors. More 
efforts are needed in this directions, and we hope future 
research on systems theories contributes to health network 
understanding, and to the underpinning of translational 
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